Lung clearance index during hospital admission in school-age children with cystic fibrosis

Journal of Cystic Fibrosis

Volumn 13, Issue 6, 2014, Pages 687-691

  Welsh, Liam ^a,b   Nesci, Christopher ^a   Tran, Haily ^a   Tomai, Marisol ^a   Ranganathan, Sarath ^a,b,c  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Cystic fibrosis; Lung function; Multiple breath washout; Pulmonary exacerbation

Indexed keywords

ANTIBIOTIC AGENT; NITROGEN; ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; ANTIBIOTIC THERAPY; ARTICLE; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CYSTIC FIBROSIS; DRUG RESPONSE; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; LUNG CLEARANCE; LUNG CLEARANCE INDEX; MALE; MULTIPLE BREATH NITROGEN WASHOUT; NITROGEN WASHOUT; PATIENT ASSESSMENT; SCHOOL CHILD; SPIROMETRY; BREATH ANALYSIS; COHORT ANALYSIS; COMPLICATION; HOSPITALIZATION; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PHYSIOLOGY; REPRODUCIBILITY; RESPIRATORY EXCRETION; YOUNG ADULT;

ADOLESCENT; ANTI-BACTERIAL AGENTS; BREATH TESTS; CHILD; COHORT STUDIES; CYSTIC FIBROSIS; FEMALE; FORCED EXPIRATORY VOLUME; HOSPITALIZATION; HUMANS; MALE; OUTCOME ASSESSMENT (HEALTH CARE); PULMONARY ELIMINATION; REPRODUCIBILITY OF RESULTS; SPIROMETRY; YOUNG ADULT;

EID: 84911981936     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/j.jcf.2014.05.012     Document Type: Article

References (23)

1. Hoo A.F., Thia L.P., Nguyen T.T., Bush A., Chudleigh J., Lum S., London Cystic Fibrosis C., et al. Lung function is abnormal in 3-month-old infants with cystic fibrosis diagnosed by newborn screening. Thorax 2012, 67:874-881.
2. Stick S.M., Brennan S., Murray C., Douglas T., von Ungern-Sternberg B.S., Garratt L.W., Australian Respiratory Early Surveillance Team for Cystic F., et al. Bronchiectasis in infants and preschool children diagnosed with cystic fibrosis after newborn screening. J Pediatr 2009, 155(e621):623-628.
3. Welsh L., Robertson C.F., Ranganathan S.C. Increased rate of lung function decline in Australian adolescents with cystic fibrosis. Pediatr Pulmonol 2013, (in press). 10.1002/ppul.22946.
4. Aurora P., Stanojevic S., Wade A., Oliver C., Kozlowska W., Lum S., London Cystic Fibrosis C., et al. Lung clearance index at 4years predicts subsequent lung function in children with cystic fibrosis. Am J Respir Crit Care Med 2011, 183:752-758.
5. Robinson P.D., Cooper P., Van Asperen P., Fitzgerald D., Selvadurai H. Using index of ventilation to assess response to treatment for acute pulmonary exacerbation in children with cystic fibrosis. Pediatr Pulmonol 2009, 44:733-742.
6. Horsley A.R., Davies J.C., Gray R.D., Macleod K.A., Donovan J., Aziz Z.A., et al. Changes in physiological, functional and structural markers of cystic fibrosis lung disease with treatment of a pulmonary exacerbation. Thorax 2013, 68:532-539.
7. Yammine S., Bigler A., Casaulta C., Singer F., Latzin P. Reasons for heterogeneous change in LCI in children with cystic fibrosis after antibiotic treatment. Thorax 2014, 69:183.
8. Welsh L., Tomai M., Tran H., Ranganathan S. Lung clearance index during pulmonary exacerbation in school-age children with cystic fibrosis. European Respiratory Society Annual Congress 2013, European Respiratory Journal, Barcelona, Spain.
9. Cole T.J., Freeman J.V., Preece M.A. British 1990 growth reference centiles for weight, height, body mass index and head circumference fitted by maximum penalized likelihood. Stat Med 1998, 17:407-429.
10. Robinson P.D., Latzin P., Verbanck S., Hall G.L., Horsley A., Gappa M., et al. Consensus statement for inert gas washout measurement using multiple- and single-breath tests. Eur. Respir. J. 2013, 41:507-522.
11. Vermeulen F., Proesmans M., Boon M., Havermans T., De Boeck K. Lung clearance index predicts pulmonary exacerbations in young patients with cystic fibrosis. Thorax 2014, 69:39-45.
12. Miller M.R., Hankinson J., Brusasco V., Burgos F., Casaburi R., Coates A., et al. Standardisation of spirometry. Eur. Respir. J. 2005, 26:319-338.
13. Quanjer P.H., Stanojevic S., Cole T.J., Baur X., Hall G.L., Culver B.H., et al. Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur. Respir. J. 2012, 40:1324-1343.
14. Ordonez C.L., Henig N.R., Mayer-Hamblett N., Accurso F.J., Burns J.L., Chmiel J.F., et al. Inflammatory and microbiologic markers in induced sputum after intravenous antibiotics in cystic fibrosis. Am J Respir Crit Care Med 2003, 168:1471-1475.
15. Sanders D.B., Bittner R.C., Rosenfeld M., Hoffman L.R., Redding G.J., Goss C.H. Failure to recover to baseline pulmonary function after cystic fibrosis pulmonary exacerbation. Am J Respir Crit Care Med 2010, 182:627-632.
16. Sanders D.B., Hoffman L.R., Emerson J., Gibson R.L., Rosenfeld M., Redding G.J., et al. Return of FEV1 after pulmonary exacerbation in children with cystic fibrosis. Pediatr Pulmonol 2010, 45:127-134.
17. Smith A.L., Fiel S.B., Mayer-Hamblett N., Ramsey B., Burns J.L. Susceptibility testing of Pseudomonas aeruginosa isolates and clinical response to parenteral antibiotic administration: lack of association in cystic fibrosis. Chest 2003, 123:1495-1502.
18. Aurora P., Bush A., Gustafsson P., Oliver C., Wallis C., Price J., London Cystic Fibrosis C., et al. Multiple-breath washout as a marker of lung disease in preschool children with cystic fibrosis. Am J Respir Crit Care Med 2005, 171:249-256.
19. Aurora P., Gustafsson P., Bush A., Lindblad A., Oliver C., Wallis C.E., et al. Multiple breath inert gas washout as a measure of ventilation distribution in children with cystic fibrosis. Thorax 2004, 59:1068-1073.
20. Gustafsson P.M., Aurora P., Lindblad A. Evaluation of ventilation maldistribution as an early indicator of lung disease in children with cystic fibrosis. Eur. Respir. J. 2003, 22:972-979.
21. Horsley A.R., Gustafsson P.M., Macleod K.A., Saunders C., Greening A.P., Porteous D.J., et al. Lung clearance index is a sensitive, repeatable and practical measure of airways disease in adults with cystic fibrosis. Thorax 2008, 63:135-140.
22. Fuchs S.I., Toussaint S., Edlhaimb B., Ballmann M., Gappa M. Short-term effect of physiotherapy on variability of the lung clearance index in children with cystic fibrosis. Pediatr Pulmonol 2010, 45:301-306.
23. Pfleger A., Steinbacher E., Weinhandl M., Wagner E., Eber E. Short-term effects of physiotherapy on ventilation inhomogeneity in cystic fibrosis patients with moderate to severe lung disease. European Respiratory Society Annual Congress 2013, European Respiratory Journal, Barcelona, Spain.